Immunome Inc. SEC filings IMNM

Immunome Inc. has 460 filings in SEC EDGAR's recent list, going back to Sep 14, 2009. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 5, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.

Immunome Inc. SEC filings
Form Description Filed Period
8-K Current report
Material agreement, Unregistered share sale
Oct 5, 2026 Oct 2, 2026
S-8 Employee stock plan registration Aug 11, 2026 —
10-Q Quarterly report Aug 11, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 11, 2026 Aug 11, 2026
8-K Current report
Shareholder vote results
Jun 12, 2026 Jun 9, 2026
10-Q Quarterly report May 12, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 12, 2026 May 12, 2026
ARS Annual report to shareholders Apr 24, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 24, 2026 —
DEF 14A Proxy statement Apr 24, 2026 Jun 9, 2026
S-8 Employee stock plan registration Mar 3, 2026 —
10-K Annual report Mar 3, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 3, 2026 Mar 3, 2026
8-K Current report
Other events
Dec 17, 2025 Dec 16, 2025
424B5 Prospectus supplement Dec 17, 2025 —
424B5 Prospectus supplement Dec 15, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Dec 15, 2025 Dec 15, 2025
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
8-K Current report
Shareholder vote results
Jun 11, 2025 Jun 10, 2025
10-Q Quarterly report May 12, 2025 Mar 31, 2025
8-K Current report
Results of operations, Other events
May 12, 2025 May 8, 2025
ARS Annual report to shareholders Apr 24, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 24, 2025 —
DEF 14A Proxy statement Apr 24, 2025 Jun 10, 2025
S-8 Employee stock plan registration Mar 19, 2025 —
10-K Annual report Mar 19, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 19, 2025 Mar 19, 2025
8-K Current report
Other events
Jan 30, 2025 Jan 29, 2025
424B5 Prospectus supplement Jan 30, 2025 —
424B5 Prospectus supplement Jan 29, 2025 —
8-K Current report
Results of operations, Other events
Jan 29, 2025 Jan 29, 2025
8-K Current report
Officer or director change
Jan 23, 2025 Jan 21, 2025
S-3ASR Automatic shelf registration Nov 22, 2024 —
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 13, 2024 Nov 13, 2024
8-K Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Unregistered share sale
Oct 29, 2024 Oct 25, 2024
S-3ASR Automatic shelf registration Oct 8, 2024 —
8-K Current report
Other events
Oct 8, 2024 Oct 3, 2024
10-Q Quarterly report Aug 12, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 12, 2024 Aug 12, 2024
8-K Current report
Shareholder vote results
Jun 13, 2024 Jun 12, 2024
424B5 Prospectus supplement May 14, 2024 —
10-Q Quarterly report May 14, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 14, 2024 May 14, 2024
8-K Current report
Officer or director change
Apr 30, 2024 Apr 24, 2024
ARS Annual report to shareholders Apr 26, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 12, 2024
8-K Current report
Officer or director change
Apr 25, 2024 Apr 25, 2024
S-3ASR Automatic shelf registration Apr 3, 2024 —
S-3ASR Automatic shelf registration Apr 3, 2024 —
10-K Annual report Mar 28, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 28, 2024 Mar 28, 2024
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Regulation FD disclosure
Mar 26, 2024 Mar 25, 2024
8-K Current report
Other events
Feb 14, 2024 Feb 13, 2024
424B5 Prospectus supplement Feb 14, 2024 —
424B5 Prospectus supplement Feb 13, 2024 —
8-K Current report
Results of operations, Other events
Feb 13, 2024 Feb 13, 2024
S-3ASR Automatic shelf registration Feb 13, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Feb 6, 2024 Feb 5, 2024
S-8 Employee stock plan registration Feb 2, 2024 —
8-K Current report
Officer or director change
Feb 1, 2024 Jan 31, 2024
8-K Current report
Regulation FD disclosure
Jan 11, 2024 Jan 11, 2024
8-K Current report
Material agreement, Unregistered share sale
Jan 8, 2024 Jan 5, 2024
8-K Current report
Officer or director change
Jan 2, 2024 Jan 2, 2024
8-K Current report
Officer or director change
Dec 29, 2023 Dec 22, 2023
8-K Current report
Other events
Dec 26, 2023 Dec 22, 2023
EFFECT Filing Nov 27, 2023 —
CORRESP Letter to the SEC Nov 22, 2023 —
8-K/A Amended current report Nov 22, 2023 Sep 29, 2023
UPLOAD Letter from the SEC Nov 20, 2023 —
S-3 Shelf registration Nov 16, 2023 —
8-K Current report
Regulation FD disclosure
Nov 15, 2023 Nov 15, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Officer or director change
Nov 8, 2023 Nov 7, 2023
S-8 POS Filing Nov 2, 2023 —
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Other events
Oct 4, 2023 Sep 29, 2023
425 Filing Sep 21, 2023 —
8-K Current report
Other events
Sep 21, 2023 Sep 21, 2023
EFFECT Filing Aug 28, 2023 —
424B3 Prospectus Aug 28, 2023 —
CORRESP Letter to the SEC Aug 25, 2023 —
S-4/A Filing Aug 25, 2023 —
UPLOAD Letter from the SEC Aug 11, 2023 —
8-K Current report
Results of operations
Aug 9, 2023 Aug 9, 2023
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
S-4 Registration for a merger or exchange Aug 8, 2023 —
425 Filing Jul 5, 2023 —
8-K Current report
Other events
Jul 5, 2023 Jul 5, 2023
425 Filing Jun 29, 2023 —
425 Filing Jun 29, 2023 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Jun 29, 2023 Jun 28, 2023
8-K Current report
Shareholder vote results
Jun 13, 2023 Jun 7, 2023
8-K Current report
Results of operations
May 5, 2023 May 5, 2023
10-Q Quarterly report May 5, 2023 Mar 31, 2023
ARS Annual report to shareholders Apr 20, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 20, 2023 —
DEF 14A Proxy statement Apr 20, 2023 Jun 7, 2023
PRE 14A Preliminary proxy statement Apr 7, 2023 Jun 7, 2023
424B5 Prospectus supplement Mar 16, 2023 —
S-8 Employee stock plan registration Mar 16, 2023 —
8-K Current report
Results of operations
Mar 16, 2023 Mar 16, 2023
10-K Annual report Mar 16, 2023 Dec 31, 2022
8-K Current report
Other events
Jan 30, 2023 Jan 30, 2023
8-K Current report
Material agreement, Regulation FD disclosure
Jan 6, 2023 Jan 4, 2023
8-K Current report
Material agreement, Other events
Jan 6, 2023 Jan 4, 2023
8-K Current report
Other events
Nov 15, 2022 Nov 15, 2022
8-K Current report
Results of operations
Nov 14, 2022 Nov 14, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Auditor change
Oct 6, 2022 Sep 30, 2022
8-K Current report
Material agreement, Change to shareholder rights
Sep 2, 2022 Sep 2, 2022
8-K Current report
Results of operations
Aug 5, 2022 Aug 5, 2022
10-Q Quarterly report Aug 5, 2022 Jun 30, 2022
8-K Current report
Other events
Jul 6, 2022 Jul 6, 2022
8-K Current report
Shareholder vote results
Jun 17, 2022 Jun 15, 2022
8-K Current report
Regulation FD disclosure, Other events
Jun 9, 2022 Jun 9, 2022
8-K Current report
Other events
May 19, 2022 May 19, 2022
8-K Current report
Results of operations
May 12, 2022 May 12, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022
DEFA14A Additional proxy material Apr 29, 2022 —
DEF 14A Proxy statement Apr 29, 2022 Jun 15, 2022
8-K Current report
Results of operations
Mar 28, 2022 Mar 28, 2022
10-K Annual report Mar 28, 2022 Dec 31, 2021
8-K Current report
Other events
Mar 11, 2022 Mar 11, 2022
8-K Current report
Other events
Feb 8, 2022 Feb 8, 2022
8-K Current report
Other events
Jan 10, 2022 Jan 10, 2022
8-K Current report
Other events
Nov 29, 2021 Nov 29, 2021
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
8-K Current report
Regulation FD disclosure
Oct 18, 2021 Oct 18, 2021
EFFECT Filing Oct 14, 2021 —
CORRESP Letter to the SEC Oct 12, 2021 —
UPLOAD Letter from the SEC Oct 8, 2021 —
S-3 Shelf registration Oct 1, 2021 —
8-K Current report
Regulation FD disclosure
Sep 21, 2021 Sep 21, 2021
8-K Current report
Other events
Sep 8, 2021 Sep 7, 2021
10-Q Quarterly report Aug 16, 2021 Jun 30, 2021
8-K Current report
Officer or director change
Aug 5, 2021 Aug 1, 2021
8-K Current report
Regulation FD disclosure, Other events
Jul 20, 2021 Jul 20, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 17, 2021 Jun 16, 2021
EFFECT Filing Jun 1, 2021 —
8-K Current report
Material agreement, Shareholder vote results
Jun 1, 2021 May 27, 2021
CORRESP Letter to the SEC May 28, 2021 —
S-1/A Amended registration statement May 26, 2021 —
CORRESP Letter to the SEC May 21, 2021 —
S-1/A Amended registration statement May 21, 2021 —
8-K Current report
Material agreement, Other events
May 20, 2021 May 19, 2021
UPLOAD Letter from the SEC May 17, 2021 —
10-Q Quarterly report May 12, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 12, 2021 May 12, 2021
S-1 Registration statement May 11, 2021 —
D Filing May 11, 2021 —
8-K Current report
Regulation FD disclosure
Apr 26, 2021 Apr 26, 2021
8-K Current report
Material agreement, Unregistered share sale, Other events
Apr 26, 2021 Apr 26, 2021
8-K Current report
Officer or director change
Apr 20, 2021 Apr 19, 2021
DEFA14A Additional proxy material Apr 16, 2021 —
DEF 14A Proxy statement Apr 16, 2021 May 27, 2021
8-K Current report
Regulation FD disclosure
Mar 29, 2021 Mar 29, 2021
8-K Current report
Results of operations
Mar 25, 2021 Mar 25, 2021
S-8 Employee stock plan registration Mar 25, 2021 —
10-K Annual report Mar 25, 2021 Dec 31, 2020
8-K Current report
Regulation FD disclosure
Mar 16, 2021 Mar 15, 2021
8-K Current report
Officer or director change
Dec 4, 2020 Nov 30, 2020
8-K Current report
Results of operations
Nov 17, 2020 Nov 17, 2020
10-Q Quarterly report Nov 16, 2020 Sep 30, 2020
8-K Current report
Regulation FD disclosure
Oct 26, 2020 Oct 26, 2020
8-K Current report
Bylaw or fiscal year change, Other events
Oct 6, 2020 Oct 6, 2020
424B4 Prospectus Oct 5, 2020 —
EFFECT Filing Oct 1, 2020 —
S-1MEF Filing Oct 1, 2020 —
CERT Filing Oct 1, 2020 —
SEC STAFF LETTER Filing Sep 30, 2020 —
8-A12B Filing Sep 30, 2020 —
CORRESP Letter to the SEC Sep 29, 2020 —
CORRESP Letter to the SEC Sep 29, 2020 —
S-1/A Amended registration statement Sep 24, 2020 —
SEC STAFF LETTER Filing Sep 21, 2020 —
CORRESP Letter to the SEC Sep 9, 2020 —
S-1 Registration statement Sep 9, 2020 —
UPLOAD Letter from the SEC Sep 1, 2020 —
DRS Filing Aug 12, 2020 —
D/A Filing Jun 16, 2020 —
D Filing Jun 1, 2020 —
D Filing Nov 19, 2019 —
D/A Filing May 29, 2019 —
D Filing Feb 1, 2019 —
D Filing May 30, 2017 —
D Filing Jul 14, 2016 —
D Filing Dec 2, 2015 —
D/A Filing Apr 13, 2015 —
D Filing Oct 14, 2014 —
D/A Filing Mar 19, 2014 —
D Filing Mar 3, 2014 —
D Filing Feb 20, 2013 —
D Filing Jan 27, 2012 —
D/A Filing Jun 8, 2011 —
D/A Filing Oct 5, 2010 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
IMNM (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Bothell, WA
SEC filer status
Non-accelerated filer
SEC CIK
1472012

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.